RLAY - Relay Therapeutics GAAP EPS of -$0.81 beats by $0.01 revenue of $0.12M misses by $0.59M August, 08 2023 04:32 PM Relay Therapeutics Inc. 2023-08-08 16:32:54 ET Relay Therapeutics press release ( NASDAQ: RLAY ): Q2 GAAP EPS of -$0.81 beats by $0.01 . Revenue of $0.12M (-67.6% Y/Y) misses by $0.59M . For further details see: Relay Therapeutics GAAP EPS of -$0.81 beats by $0.01, revenue of $0.12M misses by $0.59M